Filing Details
- Accession Number:
- 0001298711-25-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-11 17:45:38
- Reporting Period:
- 2025-07-09
- Filing Date:
- 2025-07-11
- Accepted Time:
- 2025-07-11 17:45:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1711279 | Krystal Biotech Inc. | KRYS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1298711 | Suma Krishnan | C/O Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 15203 | President, R&D | Yes | Yes | Yes | No |
Transaction Summary
| Sold: | 14,127 shares | Avg. Price: $150.27 | Total Value: $2,122,834.96 |
| Number of Shares After Transactions: | 1,525,929 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-07-09 | 200 | $150.14 | 1,463,511 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-10 | 6,500 | $150.23 | 1,457,011 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-10 | 300 | $151.39 | 1,456,711 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-09 | 200 | $150.07 | 1,532,856 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Disposition | 2025-07-10 | 6,627 | $150.22 | 1,526,229 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Disposition | 2025-07-10 | 300 | $151.39 | 1,525,929 | No | 4 | S | Indirect | By Spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 90,000 | Indirect | By SMK Trust |
| Common Stock | 50,000 | Indirect | By Krishnan Family Trust |
Footnotes
- The sales reported were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person that started on September 12, 2024 and will terminate on September 13, 2025 .
- The transaction was executed in multiple trades ranging from $150.1200 to $150.1600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in multiple trades ranging from $150.0000 to $150.8500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The transaction was executed in three trades of 100 shares each at $151.350, $151.40, and $151.41, respectively. The price reported above reflects the average sale price.
- Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.
- The sales reported were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish S. Krishnan, that started on September 12, 2024 and will terminate on September 13, 2025.
- The transaction was executed in two trades of 100 shares each at $150 and $150.14, respectively. The price reported above reflects the average sale price.
- Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person.
Billionaire Hedge Funds
